Molecular Detection of Exosomal MiRNAs of Blood Serum for Prognosis of Colorectal Cancer

Overview

Journal Sci Rep

Specialty Science

Date 2024 Apr 17

PMID 38632250

Authors

Tahani Bakhsh

Safiah Alhazmi

Ali Farsi

Abdulaziz S Yusuf

Amani Alharthi

Safa H Qahl

Maha Ali Alghamdi

Faisal A Alzahrani

Ola H Elgaddar

Mohanad A Ibrahim

Ahmed Bahieldin

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is the third most common cancer affecting people. The discovery of new, non-invasive, specific, and sensitive molecular biomarkers for CRC may assist in the diagnosis and support therapeutic decision making. Exosomal miRNAs have been demonstrated in carcinogenesis and CRC development, which makes these miRNAs strong biomarkers for CRC. Deep sequencing allows a robust high-throughput informatics investigation of the types and abundance of exosomal miRNAs. Thus, exosomal miRNAs can be efficiently examined as diagnostic biomarkers for disease screening. In the present study, a number of 660 mature miRNAs were detected in patients diagnosed with CRC at different stages. Of which, 29 miRNAs were differentially expressed in CRC patients compared with healthy controls. Twenty-nine miRNAs with high abundance levels were further selected for subsequent analysis. These miRNAs were either highly up-regulated (e.g., let-7a-5p, let-7c-5p, let-7f-5p, let-7d-3p, miR-423-5p, miR-3184-5p, and miR-584) or down-regulated (e.g., miR-30a-5p, miR-99-5p, miR-150-5p, miR-26-5p and miR-204-5p). These miRNAs influence critical genes in CRC, leading to either tumor growth or suppression. Most of the reported diagnostic exosomal miRNAs were shown to be circulating in blood serum. The latter is a novel miRNA that was found in exosomal profile of blood serum. Some of the predicted target genes of highly expressed miRNAs participate in several cancer pathways, including CRC pathway. These target genes include tumor suppressor genes, oncogenes and DNA repair genes. Main focus was given to multiple critical signaling cross-talking pathways including transforming growth factor β (TGFβ) signaling pathways that are directly linked to CRC. In conclusion, we recommend further analysis in order to experimentally confirm exact relationships between selected differentially expressed miRNAs and their predicted target genes and downstream functional consequences.

Citing Articles

Combinatorial Analysis of miRNAs and tRNA Fragments as Potential Biomarkers for Cancer Patients in Liquid Biopsies.

Glogovitis I, DAmbrosi S, Antunes-Ferreira M, Chiogna M, Yahubyan G, Baev V Noncoding RNA. 2025; 11(1).

PMID: 39997617 PMC: 11858735. DOI: 10.3390/ncrna11010017.

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.

References

Ghanbari R, Mosakhani N, Sarhadi V, Armengol G, Nouraee N, Mohammadkhani A . Simultaneous Underexpression of let-7a-5p and let-7f-5p microRNAs in Plasma and Stool Samples from Early Stage Colorectal Carcinoma. Biomark Cancer. 2016; 7(Suppl 1):39-48. PMC: 4711391. DOI: 10.4137/BIC.S25252. View

Koshizuka K, Hanazawa T, Arai T, Okato A, Kikkawa N, Seki N . Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma. Cancer Metastasis Rev. 2017; 36(3):525-545. DOI: 10.1007/s10555-017-9692-y. View

Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y . Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol. 2010; 6(4):e1000730. PMC: 2848541. DOI: 10.1371/journal.pcbi.1000730. View

Yu J, Feng Y, Wang Y, An R . Aryl hydrocarbon receptor enhances the expression of miR-150-5p to suppress in prostate cancer progression by regulating MAP3K12. Arch Biochem Biophys. 2018; 654:47-54. DOI: 10.1016/j.abb.2018.07.010. View

Guo L, Lu Z . The fate of miRNA* strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule?. PLoS One. 2010; 5(6):e11387. PMC: 2894941. DOI: 10.1371/journal.pone.0011387. View

Zhong M, Bian Z, Wu Z . miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell Physiol Biochem. 2013; 31(2-3):209-18. DOI: 10.1159/000343362. View

Ingenito F, Roscigno G, Affinito A, Nuzzo S, Scognamiglio I, Quintavalle C . The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications. Int J Mol Sci. 2019; 20(19). PMC: 6801421. DOI: 10.3390/ijms20194687. View

Bao W, Wang H, Tian F, He X, Qiu M, Wang J . A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol Cancer. 2013; 12:155. PMC: 3879200. DOI: 10.1186/1476-4598-12-155. View

Li X, Zhou J, Chen Z, Chng W . P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation. World J Gastroenterol. 2015; 21(1):84-93. PMC: 4284363. DOI: 10.3748/wjg.v21.i1.84. View

10.

Choo K, Soon Y, Nguyen P, Hiew M, Huang C . MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells. J Biomed Sci. 2014; 21:95. PMC: 4195866. DOI: 10.1186/s12929-014-0095-x. View

11.

Palma J, Yaddanapudi S, Pigati L, Havens M, Jeong S, Weiner G . MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res. 2012; 40(18):9125-38. PMC: 3467054. DOI: 10.1093/nar/gks656. View

12.

He Z, Dang J, Song A, Cui X, Ma Z, Zhang Y . The involvement of miR-150/β-catenin axis in colorectal cancer progression. Biomed Pharmacother. 2019; 121:109495. DOI: 10.1016/j.biopha.2019.109495. View

13.

Lim L, Lau N, Weinstein E, Abdelhakim A, Yekta S, Rhoades M . The microRNAs of Caenorhabditis elegans. Genes Dev. 2003; 17(8):991-1008. PMC: 196042. DOI: 10.1101/gad.1074403. View

14.

Toiyama Y, Okugawa Y, Fleshman J, Boland C, Goel A . MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review. Biochim Biophys Acta Rev Cancer. 2018; 1870(2):274-282. PMC: 7286572. DOI: 10.1016/j.bbcan.2018.05.006. View

15.

Gao Z, Yuan W, Yuan J, Yuan K, Wang Y . miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer. Pathol Res Pract. 2018; 214(5):700-705. DOI: 10.1016/j.prp.2018.03.013. View

16.

Feng X, Derynck R . Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol. 2005; 21:659-93. DOI: 10.1146/annurev.cellbio.21.022404.142018. View

17.

Soleimani A, Rahmani F, Saeedi N, Ghaffarian R, Khazaei M, Ferns G . The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer. J Cell Biochem. 2019; 120(12):19245-19253. DOI: 10.1002/jcb.29268. View

18.

Feng J, Yang Y, Zhang P, Wang F, Ma Y, Qin H . miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb. J Cell Mol Med. 2014; 18(10):2125-34. PMC: 4244026. DOI: 10.1111/jcmm.12398. View

19.

Guinney J, Dienstmann R, Wang X, De Reynies A, Schlicker A, Soneson C . The consensus molecular subtypes of colorectal cancer. Nat Med. 2015; 21(11):1350-6. PMC: 4636487. DOI: 10.1038/nm.3967. View

20.

Fu F, Jiang W, Zhou L, Chen Z . Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer. Transl Oncol. 2018; 11(2):221-232. PMC: 5789766. DOI: 10.1016/j.tranon.2017.12.012. View